AstraZeneca PLC (AZN)
NYSE: AZN · Real-Time Price · USD
172.48
+2.84 (1.67%)
At close: Jul 28, 2026, 4:00 PM EDT
171.00
-1.48 (-0.86%)
After-hours: Jul 28, 2026, 7:54 PM EDT

AstraZeneca Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
15,38415,28815,50315,19114,45713,58814,89113,56512,93812,67912,02411,49211,41610,87911,20710,98210,77111,39012,0119,866
Revenue Growth (YoY)
6.41%12.51%4.11%11.99%11.74%7.17%23.84%18.04%13.33%16.55%7.29%4.64%5.99%-4.49%-6.69%11.31%31.03%55.60%62.09%49.98%
Cost of Revenue
2,5232,6783,1182,8012,4732,2412,7253,0812,1832,2182,3082,0951,9601,9052,9002,9822,9983,5114,6253,757
Gross Profit
12,86112,61012,38512,39011,98411,34712,16610,48410,75510,4619,7169,3979,4568,9748,3078,0007,7737,8797,3866,109
Selling, General & Admin
5,7965,0615,6455,2335,0074,6275,5535,2885,0614,6305,5164,9295,1174,1934,7774,4034,8104,9655,2414,210
Research & Development
4,0533,4923,8623,6633,5483,1594,6773,1153,0082,7833,0732,5842,6672,6112,6252,4582,5462,1332,5843,610
Other Operating Expenses
-152-189-100-89-79-113-100-25-60-67-107-70-784-379-189-106-122-97-147-37
Total Operating Expenses
9,6978,3649,4078,8078,4767,67310,1308,3788,0097,3468,4827,4437,0006,4257,2136,7557,2347,0017,6787,783
Operating Income
3,1644,2462,9783,5833,5083,6742,0362,1062,7463,1151,2341,9542,4562,5491,0941,245539878-292-1,674
Interest Income
706113595587759179949810890637844161911-88
Interest Expense
-435-393-484-434-439-349-429-457-443-413-445-392-431-365-360-339-311-336-336-335
Total Non-Operating Income (Expense)
-365-332-349-339-381-272-370-278-349-315-337-302-368-287-316-323-292-325-344-327
Pretax Income
2,7993,9142,6293,2443,1273,4021,6661,8282,3972,8008971,6522,0882,262778922247553-636-2,001
Provision for Income Taxes
291833300709679481166395469620-62274268458-124-720-113165-290-350
Net Income
2,5083,0812,3292,5352,4482,9211,5001,4331,9282,1809591,3781,8201,8049021,642360388-346-1,651
Minority Interest in Earnings
1132-25-411-142112-211
Net Income to Common
2,5073,0802,3262,5332,4502,9161,5001,4291,9272,1799601,3741,8181,8039011,640360386-347-1,652
Net Income Growth (YoY)
2.33%5.62%55.07%77.26%27.14%33.82%56.25%4.00%6.00%20.85%6.55%-16.22%405.00%367.10%---34.54%-75.27%--
Shares Outstanding (Basic)
1,5511,5491,5511,5511,5501,5501,5501,5501,5501,5491,5491,5491,5501,5491,5491,5481,5491,5481,5471,496
Shares Outstanding (Diluted)
1,5601,5611,5631,5611,5591,5611,5621,5621,5601,5601,5611,5601,5601,5601,5591,5591,5601,5611,5471,496
Shares Change (YoY)
0.06%-0.06%-0.06%-0.06%0.06%0.06%0.13%--0.13%0.06%--0.06%0.78%4.21%18.36%18.35%17.82%13.94%
EPS (Basic)
1.611.991.501.641.581.880.970.921.241.410.620.891.171.160.581.060.230.25-0.22-1.10
EPS (Diluted)
1.611.971.491.621.571.870.960.911.241.400.620.881.171.160.581.050.230.25-0.22-1.10
EPS Growth (YoY)
2.55%5.35%55.21%78.02%26.61%33.57%54.84%3.41%5.98%20.69%6.90%-16.19%408.70%364.00%---45.24%-78.81%--
Free Cash Flow
2,1022,8121,3064,4482,7273,2842,1992,9662,7032,0691,8552,7951,4482,8862,0262,6839953,0131,0951,459
Free Cash Flow Growth (YoY)
-22.92%-14.37%-40.61%49.97%0.89%58.72%18.54%6.12%86.67%-28.31%-8.44%4.17%45.53%-4.21%85.02%83.89%64.73%75.79%-23.69%-8.47%
Free Cash Flow Per Share
1.351.800.842.851.752.101.411.901.731.331.191.790.931.851.301.720.641.930.710.98
Dividends Per Share
0.011-2.170-1.030-2.100-1.000-1.970-0.930-1.970-0.930-1.970-
Dividend Growth (YoY)
-98.97%-3.33%-3.00%-6.60%-7.53%-0%-0%-0%-----
Gross Margin
83.60%82.48%79.89%81.56%82.89%83.51%81.70%77.29%83.13%82.51%80.81%81.77%82.83%82.49%74.12%72.85%72.17%69.17%61.49%61.92%
Operating Margin
20.57%27.77%19.21%23.59%24.27%27.04%13.67%15.53%21.22%24.57%10.26%17.00%21.51%23.43%9.76%11.34%5.00%7.71%-2.43%-16.97%
Profit Margin
16.30%20.15%15.02%16.69%16.93%21.50%10.07%10.56%14.90%17.19%7.98%11.99%15.94%16.58%8.05%14.95%3.34%3.41%-2.88%-16.73%
FCF Margin
13.66%18.39%8.42%29.28%18.86%24.17%14.77%21.87%20.89%16.32%15.43%24.32%12.68%26.53%18.08%24.43%9.24%26.45%9.12%14.79%
EBITDA
5,0935,6124,4895,1324,8974,9584,3733,9234,0254,3702,5613,2363,7324,0512,5742,5791,8962,1871,9001,114
EBITDA Margin
33.11%36.71%28.96%33.78%33.87%36.49%29.37%28.92%31.11%34.47%21.30%28.16%32.69%37.24%22.97%23.48%17.60%19.20%15.82%11.29%
EBIT
3,1644,2462,9783,5833,5083,6742,0362,1062,7463,1151,2341,9542,4562,5491,0941,245539878-292-1,674
EBIT Margin
20.57%27.77%19.21%23.59%24.27%27.04%13.67%15.53%21.22%24.57%10.26%17.00%21.51%23.43%9.76%11.34%5.00%7.71%-2.43%-16.97%
Effective Tax Rate
10.40%21.28%11.41%21.86%21.71%14.14%9.96%21.61%19.57%22.14%-6.91%16.59%12.84%20.25%-15.94%-78.09%-45.75%29.84%45.60%17.49%
SEC Filings: 10-K · 10-Q